Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 25,005
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12605342 | Polymer-encapsulated drug particles | 🖼🧊📄§ | 2026-04-21 | 2044-04-10 | 0 | 31 |
| 12606605 | Ultra-long acting insulin-Fc fusion proteins and methods of use | 🖼🧊📄§ | 2026-04-21 | 2043-01-10 | 0 | 31 |
| 12605416 | Compositions and methods for the treatment of skin diseases and conditions including eczema | 🖼🧊📄§ | 2026-04-21 | 2044-12-27 | 0 | 31 |
| 12605376 | Methods of treating relapsing multiple sclerosis using an inhibitor of Bruton's tyrosine kinase | 🖼🧊📄§ | 2026-04-21 | 2041-04-01 | 0 | 31 |
| 12605445 | Hematopoietic stem cells in combinatorial therapy with immune checkpoint inhibitors against cancer | 🖼🧊📄§ | 2026-04-21 | 2044-01-12 | 0 | 31 |
| 12606633 | Methods and compositions for anti-CD73 antibodies and variants | 🖼🧊📄§ | 2026-04-21 | 2042-01-25 | 0 | 31 |
| 12605434 | Composition for preventing or treating autoimmune diseases | 🖼🧊📄§ | 2026-04-21 | 2042-09-13 | 0 | 31 |
| 12606610 | Compositions and methods for treatment of Netherton Syndrome with LEKTI expressing recombinant microbes | 🖼🧊📄§ | 2026-04-21 | 2043-08-16 | 0 | 31 |
| 12606623 | DLL3 targeting chimeric antigen receptors and binding agents | 🖼🧊📄§ | 2026-04-21 | 2043-04-27 | 0 | 31 |
| 12606540 | Triazolone compound | 🖼🧊📄§ | 2026-04-21 | 2041-05-24 | 0 | 31 |
| 12605371 | Combination therapy for cancer | 🖼🧊📄§ | 2026-04-21 | 2041-07-26 | 0 | 31 |
| 12605392 | Cannabinoid composition and method of treating diabetic and chemotherapy induced neuropathic pain | 🖼🧊📄§ | 2026-04-21 | 2042-06-20 | 0 | 31 |
| 12605418 | Chebulinic acid and its enriched fraction from the fruits of Terminalia chebula for treatment of benign prostatic hyperplasia (BPH) and its preparation thereof | 🖼🧊📄§ | 2026-04-21 | 2041-09-13 | 0 | 31 |
| 12606595 | Regentide-041 and composition comprising Regentide-041 for improving skin condition | 🖼🧊📄§ | 2026-04-21 | 2041-06-08 | 0 | 31 |
| 12605362 | Eletriptan hydrobromide for treatment of spinal cord injury and improvement of locomotor function | 🖼🧊📄§ | 2026-04-21 | 2040-12-21 | 0 | 31 |
| 12606609 | Polypeptides having improved properties | 🖼🧊📄§ | 2026-04-21 | 2041-01-26 | 0 | 31 |
| 12605439 | Universal influenza vaccine compositions | 🖼🧊📄§ | 2026-04-21 | 2041-12-28 | 0 | 31 |
| 12606571 | Macrocyclic compounds and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2044-04-09 | 0 | 31 |
| 12605372 | Combination therapy for the treatment of cancer | 🖼🧊📄§ | 2026-04-21 | 2042-11-09 | 0 | 31 |
| 12605380 | Methods of improving lung function | 🖼🧊📄§ | 2026-04-21 | 2045-09-12 | 0 | 31 |
| 12605466 | Enhanced human opsin promoter for rod specific expression | 🖼🧊📄§ | 2026-04-21 | 2040-03-04 | 0 | 31 |
| 12606558 | Condensed pyrazole derivatives as inhibitors of SARM1 | 🖼🧊📄§ | 2026-04-21 | 2041-04-07 | 0 | 31 |
| 12605375 | Use of CSF-1R kinase inhibitor | 🖼🧊📄§ | 2026-04-21 | 2041-02-26 | 0 | 31 |
| 12605430 | High-activity blood coagulation factor XI mutant Ala570Thr | 🖼🧊📄§ | 2026-04-21 | 2041-04-13 | 0 | 31 |
| 12605331 | Composition comprising iris-derived exosome as active ingredient | 🖼🧊📄§ | 2026-04-21 | 2043-12-27 | 0 | 31 |
| 12605397 | Deoxy-cytidine or uridine derivatives for use in cancer therapies | 🖼🧊📄§ | 2026-04-21 | 2044-03-12 | 0 | 31 |
| 12605349 | Methods of treating grade 3 astrocytoma | 🖼🧊📄§ | 2026-04-21 | 2044-12-11 | 0 | 31 |
| 12606805 | Tymovirus virus and virus-like particles as nanocarriers for imaging and therapeutic agents | 🖼🧊📄§ | 2026-04-21 | 2043-08-29 | 0 | 31 |
| 12606630 | CD25 chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2040-08-28 | 0 | 31 |
| 12606827 | Compounds for treatment of osteoarthritis | 🖼🧊📄§ | 2026-04-21 | 2043-05-19 | 0 | 31 |
| 12605356 | Methods of treating pancreatic cancer | 🖼🧊📄§ | 2026-04-21 | 2043-10-26 | 0 | 31 |
| 12606594 | Heterotandem bicyclic peptide complexes | 🖼🧊📄§ | 2026-04-21 | 2042-02-02 | 0 | 31 |
| 12606618 | Antagonist anti-NPR1 antibodies and methods of use thereof | 🖼🧊📄§ | 2026-04-21 | 2042-12-06 | 0 | 31 |
| 12606635 | Glypican-2-binding moieties, chimeric antigen receptors and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-03-12 | 0 | 31 |
| 12605419 | Flavonoid extract of Cyclocarya paliurus leaves and antibacterial drugs and/or antibacterial agents containing thereof | 🖼🧊📄§ | 2026-04-21 | 2040-08-20 | 0 | 31 |
| 12606620 | Anti-LILRB1 antibody and uses thereof | 🖼🧊📄§ | 2026-04-21 | 2041-07-27 | 0 | 31 |
| 12605417 | Compositions and methods for ameliorating symptoms associated with inflammatory skin disorders | 🖼🧊📄§ | 2026-04-21 | 2044-09-27 | 0 | 31 |
| 12606598 | Chimeric klebicins | 🖼🧊📄§ | 2026-04-21 | 2042-07-08 | 0 | 31 |
| 12599588 | Inhibitor for V-ATPase activity, antibacterial agent, medicine, antibacterial method and screening method | 🖼🧊📄§ | 2026-04-14 | 2040-01-15 | 0 | 31 |
| 12600785 | Method of screening for compounds that inhibit proliferation of pancreatic cancer cells having a loss-of-function mutation in the RNF43 gene | 🖼🧊📄§ | 2026-04-14 | 2041-02-15 | 0 | 31 |
| 12600964 | Compound for treatment of heart failure | 🖼🧊📄§ | 2026-04-14 | 2041-11-17 | 0 | 31 |
| 12599573 | Compositions and uses thereof in treating cancers | 🖼🧊📄§ | 2026-04-14 | 2043-03-17 | 0 | 31 |
| 12599591 | Vemurafenib and salts thereof for use in the treatment of enteroviral infections | 🖼🧊📄§ | 2026-04-14 | 2039-10-03 | 0 | 31 |
| 12599698 | Therapeutic article of manufacture with nanoparticles to promote wound healing and/or antimicrobial infection control | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12599638 | Feed and composition comprising lactic acid bacteria and fatty acid | 🖼🧊📄§ | 2026-04-14 | 2041-09-21 | 0 | 31 |
| 12599323 | Methods and systems for treating pregnancy-related hypertensive disorders comprising anti-sEng and anti-sFlt-1 antibodies | 🖼🧊📄§ | 2026-04-14 | 2040-12-08 | 0 | 31 |
| 12600716 | Compounds for modulating activity of FXR and uses thereof | 🖼🧊📄§ | 2026-04-14 | 2040-10-12 | 0 | 31 |
| 12599153 | Compositions and methods for reducing greenhouse gas | 🖼🧊📄§ | 2026-04-14 | 2043-03-23 | 0 | 31 |
| 12599617 | Methods of treating head and neck cancers with hemp extract | 🖼🧊📄§ | 2026-04-14 | 2042-10-26 | 0 | 31 |
| 12599635 | Compositions and treatments for ischemic injuries | 🖼🧊📄§ | 2026-04-14 | 2041-03-22 | 0 | 31 |